.
Aptevo Therapeutics is headquartered in Seattle, Washington.
Aptevo Therapeutics is a life science company.
Aptevo Therapeutics was founded in 2016.
Join Mergr to view all 0 acquisitions of life science companies in , including .
2401 4th Avenue, Suite 1050,
Seattle, Washington
98101
United States,
www.aptevotherapeutics.com
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. Company leverage the innovative ADAPTIR platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST.
| Year | ≤ '19 | '20 | '21 | '22 | '23 | '24 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | - | - | - | - | - | - | 0 |
| Sell (0.2/yr) | # | 1 | 1 | - | - | - | - | 2 |
| vol | $75M | $30M | $105M | |||||
| 2 | ||||||||
| Company | Date | Value | Type |
|---|---|---|---|
| Aptevo BioTherapeutics LLC | 2020-02-28 | 30M USD | Divestiture |
| Chicago, Illinois · www.ixinity.com | |||
| Aptevo Therapeutics, Inc. - Hyperimmune Commercial Products | 2017-08-31 | 75M USD | Divestiture |
| Seattle, Washington | |||
| View All >> | |||
| Sector | Buy # | Value | Sell # | Value | |
|---|---|---|---|---|---|
| Life Science | - | - | 1 (50%) | 30M (29%) | |
| Medical Products | - | - | 1 (50%) | 75M (71%) | |
| Total | - | - | 2 | $105M | |
| State/Country | Buy | Value | Sell | Value | ||
|---|---|---|---|---|---|---|
| United States | - | - | 2 | 105M | ||
| Washington | - | - | 1 | 75M | ||
| Illinois | - | - | 1 | 30M | ||
| Total | - | - | 2 | $105M | ||
| sell | # | Total |
|---|---|---|
| < $100M | 2 | $105M |
| TOTAL | $105M | |
| Largest |
Aptevo Therapeutics, Inc. - Hyperimmune Commercial Products $75M (2017-08-31) |
|
| Deals | ||
|---|---|---|
| Divested to | ||
| Strategic(s) |
|
2 (100%) |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.
